Status: current, Defined. Date: 31-Aug 2012. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 220201000036110 | Anticol Max (hexylresorcinol 2.5 mg) lozenge, 16 lozenges, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 220211000036112 | Anticol Max 2.5 mg lozenge, 16, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Anticol Max 2.5 mg lozenge, 16, blister pack | has TPUU | Anticol Max 2.5 mg lozenge | true | Inferred relationship | Some | 1 | |
| Anticol Max 2.5 mg lozenge, 16, blister pack | has TP | Anticol Max | true | Inferred relationship | Some | ||
| Anticol Max 2.5 mg lozenge, 16, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Anticol Max 2.5 mg lozenge, 16, blister pack | Is a | Anticol Max (hexylresorcinol 2.5 mg) lozenge, 16 lozenges (trade product pack) | true | Inferred relationship | Some | ||
| Anticol Max 2.5 mg lozenge, 16, blister pack | has container type | blister pack | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR